A Philadelphia biotechnology company founded seven years ago by two former Johnson & Johnson executives has a new leader.

United Therapeutics expects pig kidney transplants ... clarity and the ability to go into patients,” said Mike Curtis, CEO of eGenesis. “It creates a very clear path for us to bring this ...

A New Hampshire man fought for the chance at a pig kidney transplant, spending months getting into good enough shape to be ...

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

today provided the following letter to shareholders from the Company’s President and CEO, Gene Mack: With 2025 poised to be another pivotal year for Gain Therapeutics, I want to take a moment to ...

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), a $15.77 billion market cap company with an "Excellent" financial health rating according to InvestingPro, executed a ...

Gain Therapeutics (GANX) provided a letter to shareholders from the Company’s President and CEO, Gene Mack, which read in part,”With 2025 poised to be another pivotal year for Gain ...

Actuate Therapeutics, Inc., a biopharmaceutical company focusing on cancer therapies, announced that its CEO, Daniel Schmitt, will participate in two upcoming investor conferences: the BIO CEO ...

BASKING RIDGE, N.J., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics ... will present a corporate overview at the 2025 BIO CEO & Investor Conference taking place February 10-11, 2025 ...

Feb. 06, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq ... letter to shareholders from the Company’s President and CEO, Gene Mack: To our valued shareholders, With 2025 poised ...

Participation of CEO Michael Rossi in a prominent industry conference, enhancing visibility and credibility for Y-mAbs. Live webcast of the event provides an opportunity for investors and ...

Their #1 priority is getting fast relief and that’s what we’re uniquely positioned to deliver,” said Miist Therapeutics’ CEO and co-founder, Dalton Signor. Zal Bilimoria, GP of Refactor ...